Does BELIMUMAB Cause Inappropriate schedule of product administration? 651 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 651 reports of Inappropriate schedule of product administration have been filed in association with BELIMUMAB (BENLYSTA). This represents 2.4% of all adverse event reports for BELIMUMAB.
651
Reports of Inappropriate schedule of product administration with BELIMUMAB
2.4%
of all BELIMUMAB reports
9
Deaths
214
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From BELIMUMAB?
Of the 651 reports, 9 (1.4%) resulted in death, 214 (32.9%) required hospitalization, and 9 (1.4%) were considered life-threatening.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 651 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
Which BELIMUMAB Alternatives Have Lower Inappropriate schedule of product administration Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID